Press Release: European Medicines Agency reviews hypothesis on Pandemrix and development of narcolepsy

Author (Corporate)
Series Title
Series Details EMA/CHMP/676755/2012 (19.10.12)
Publication Date 19/10/2012
Content Type

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), in October 2012, reviewed preliminary research results by the Finnish National Institute of Health and Welfare (THL) investigating differences in the immunological response triggered by different pandemic influenza vaccines as a potential root cause for the development of narcolepsy in persons vaccinated with Pandemrix.

Narcolepsy is a rare sleep disorder that causes a person to fall asleep suddenly and unexpectedly.

Source Link Link to Main Source http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/10/news_detail_001636.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/CHMP/676755/2012 (19.10.12) http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2012/10/WC500134087.pdf

Subject Categories
Countries / Regions